Volume 141, Issue 4, Pages 1249-1253 (October 2011) Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States Michael R. Charlton, Justin M. Burns, Rachel A. Pedersen, Kymberly D. Watt, Julie K. Heimbach, Ross A. Dierkhising Gastroenterology Volume 141, Issue 4, Pages 1249-1253 (October 2011) DOI: 10.1053/j.gastro.2011.06.061 Copyright © 2011 AGA Institute Terms and Conditions
Figure 1 The frequencies of hepatitis C infection, alcoholic liver disease, NASH, and NASH + 50% CC for liver transplantation among adults in the United States between 2001 and 2009 are shown. NASH and NASH + 50% CC have increased in each of the study years. NASH is currently the third most common indication for liver transplantation. Gastroenterology 2011 141, 1249-1253DOI: (10.1053/j.gastro.2011.06.061) Copyright © 2011 AGA Institute Terms and Conditions
Figure 2 The frequencies of specific indications for liver transplantation among adults in the United States are shown. ALD, alcoholic liver disease; HBV, hepatitis B virus; CC, cryptogenic cirrhosis; PSC, primary sclerosing cholangitis; PBC, primary biliary cirrhosis; AIH, autoimmune hepatitis. Gastroenterology 2011 141, 1249-1253DOI: (10.1053/j.gastro.2011.06.061) Copyright © 2011 AGA Institute Terms and Conditions
Figure 3 Kaplan–Meier analysis showing graft survival among patients undergoing primary liver transplantation for patients with NASH, CC, and other indications for liver transplantation is shown. In this analysis, there was no significant difference in graft survival in the first 3 postoperative years. Gastroenterology 2011 141, 1249-1253DOI: (10.1053/j.gastro.2011.06.061) Copyright © 2011 AGA Institute Terms and Conditions
Figure 4 Three-year patient and graft survival according to indication for liver transplantation among adults in the United States are shown. CC, cryptogenic cirrhosis; HBV, hepatitis B virus; AIH, autoimmune hepatitis; PSC, primary sclerosing cholangitis. Gastroenterology 2011 141, 1249-1253DOI: (10.1053/j.gastro.2011.06.061) Copyright © 2011 AGA Institute Terms and Conditions